# A Phase II Study to Determine the Safety and Efficacy of Second-line Treatment With Metformin and Chemotherapy (FOLFOX6 or FOFIRI) in the Second Line Threatment of Advanced Colorectal Cancer

> **NCT01926769** · PHASE2 · TERMINATED · sponsor: **Gachon University Gil Medical Center** · enrollment: 2 (actual)

## Conditions studied

- Previously Treated Advanced Colorectal Cancer

## Interventions

- **DRUG:** Metformin

## Key facts

- **NCT ID:** NCT01926769
- **Lead sponsor:** Gachon University Gil Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2012-02
- **Primary completion:** 2014-12
- **Final completion:** 2014-12
- **Target enrollment:** 2 (ACTUAL)
- **Why stopped:** Slow accrual rate
- **Last updated:** 2018-05-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01926769

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01926769, "A Phase II Study to Determine the Safety and Efficacy of Second-line Treatment With Metformin and Chemotherapy (FOLFOX6 or FOFIRI) in the Second Line Threatment of Advanced Colorectal Cancer". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01926769. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*